Developing and validating a prognostic disulfidptosis-related signature for glioblastoma: predicting radioresistance and synergestic effect with immunotherapy
Abstract Background Programmed cell death (PCD) modulated radioresistance is one of the predominant causes of treatment failure in glioblastoma (GBM). Disulfidptosis, a newly discovered form of PCD, plays a crucial role in GBM progression. However, the association among disulfidptosis, radiosensitiv...
Saved in:
| Main Authors: | Chen Chen, Peixin Tan, Wenqing Feng, Yuan Lei, Shushu Hu, Dehuan Xie, Yantan Liu, Chen Ren, Shasha Du |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-03-01
|
| Series: | Journal of Cancer Research and Clinical Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s00432-025-06159-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel disulfidptosis-related gene signature predicts overall survival of glioblastoma patients
by: Yuxia Zhang, et al.
Published: (2024-12-01) -
Prognostic and immunotherapeutic potential of disulfidptosis-associated signature in pancreatic cancer
by: Ran Cui, et al.
Published: (2025-03-01) -
Disulfidptosis: a novel gene-based signature predicts prognosis and immunotherapy efficacy of pancreatic adenocarcinoma
by: Jingyang Yin, et al.
Published: (2025-03-01) -
Disulfidptosis-based molecular clustering and prognostic signatures predict patient survival and the immune landscape in patients with colon cancer
by: Liang Wen, et al.
Published: (2025-03-01) -
Combining immunotherapy with radiotherapy for glioblastoma: recent advances and challenges
by: Yuanyang Sun, et al.
Published: (2025-05-01)